Onconetix said its shareholders will own 10% of the combined company upon completion of the deal, slated to close in the fourth quarter, while investors in Ocuvex, which is focused on developing ...

Aptorum Group has agreed to combine with molecular-diagnostics company DiamiR Biosciences in an all-stock reverse merger. Clinical-stage biopharmaceutical company Aptorum said its shareholders will ...

Combined Company to Trade on Nasdaq Under Ticker "IMA" Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc.

Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock . BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE ...